DR. JAMES M FLECKENSTEIN, MD
Osteopathic Medicine at Jefferson Ave, Memphis, TN

License number
Tennessee 29605
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
1030 Jefferson Ave, Memphis, TN 38104
Phone
(901) 523-8990
(901) 577-7273 (Fax)

Personal information

See more information about JAMES M FLECKENSTEIN at radaris.com
Name
Address
Phone
James M Fleckenstein, age 65
6584 Pidgeon Hall, Memphis, TN 38119
(901) 757-5382

Professional information

James M Fleckenstein Photo 1

Dr. James M Fleckenstein, Saint Louis MO - MD (Doctor of Medicine)

Specialties:
Infectious Disease Medicine
Address:
915 N Grand Blvd, Saint Louis 63106
(314) 652-4100 (Phone)
FLECKENSTEIN JAMES M MD
1030 Jefferson Ave, Memphis 38104
(901) 577-7433 (Phone), (901) 577-7447 (Fax)
Memphis Office
1030 Jefferson Ave, Memphis 38104
(901) 523-8990 (Phone), (901) 577-7286 (Fax)
Certifications:
Infectious Disease, 2004, Internal Medicine, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Saint Louis University / School of Medicine
Graduated: 1985
University Of Mi Hosps and Health Ctrs
Walter Reed Army Med Center


James M Fleckenstein Photo 2

James M Fleckenstein, Memphis TN

Specialties:
Infectious Disease Specialist
Address:
1030 Jefferson Ave, Memphis, TN 38104
Education:
Saint Louis University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)


James Fleckenstein Photo 3

Prevention And Treatment Of Gram Negative, Flagellated Bacterial Infections

US Patent:
8323668, Dec 4, 2012
Filed:
Mar 26, 2008
Appl. No.:
12/079304
Inventors:
James M. Fleckenstein - Memphis TN, US
Assignee:
The University of Tennessee Research Foundation - Knoxville TN
International Classification:
A61K 39/108, A61K 39/00, A61K 39/395, A61K 45/00, A61K 39/40
US Classification:
4242571, 4241921, 4241301, 4242781, 4242411, 4241691, 4241841
Abstract:
The present invention describes a novel mechanism of adhesion by flagellated Gram-negative bacteria such as enterotoxigenic (ETEC), where the bacteria secretes a protein, EtpA which binds to the conserved region of the flagellin protein located at the tip of the flagella. The present invention also discloses that EtpA-mediated interaction and intestinal colonization require interaction with flagellin. Also disclosed herein is a vaccine composition that can be used for either active or passive immunization of mammals for the prevention or treatment of infections caused by flagellated Gram-negative bacteria.